1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Granular Cell Tumor: new trials by email Literature Review of Granular Cell Tumor trials Research Report on Granular Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
Chondrosarcoma, Extraskeletal Myxoid (1) · Dermatofibrosarcoma (1) · Disorders of Sex Development (1) · Fibrosarcoma (1) · Glomus Tumor (1) · Hemangioendothelioma, Epithelioid (1) · Hemangiosarcoma (1) · Histiocytoma, Angiomatoid Fibrous (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Liposarcoma, Myxoid (1) · Myoepithelioma (1) · Neoplasms, Adipose Tissue (1) · Nerve Sheath Neoplasms (1)
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Hemangioendothelioma (1) · Hemangioma (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
Doxorubicin (1) · Ifosfamide (1) · Proton Therapy (1) · pazopanib (1) · selinexor (1)
St. Jude Children's Research Hospital (1)
United States (1)